MQS Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

MQS Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$390K	Buy	+13,143	New	+$377K	0.23%	178

Other funds holding LKFT

Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return

MQS Management's LKFT Position: Q3 2026 in Review

MQS Management opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 13,143 shares worth $390K. The stake represents 0.23% of the portfolio and ranks #178 among its holdings.

28 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

MQS Management held 13,143 shares of Lakefront Biotherapeutics American Depositary Shares worth $390K as of Q3 2026.
Lakefront Biotherapeutics American Depositary Shares was a new MQS Management position in Q3 2026.
Lakefront Biotherapeutics American Depositary Shares made up 0.23% of MQS Management's portfolio in Q3 2026, its #178 holding.
28 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on MQS Management's 13F filing for Q3 2026, filed 6 Nov 2026.